We are live on ! Find out more
GBIO

Generation Bio

Delisted

GBIO was delisted on the 6th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$26.8M +$2.06M +63,527 +7%
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$23.3M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$15M -$96.3K -2,965 -0.6%
BG
4
Bellevue Group
Switzerland
$11.1M +$186K +5,728 +1%
BlackRock
5
BlackRock
New York
$9.29M +$797K +24,540 +8%
Bank of America
6
Bank of America
North Carolina
$8.41M -$26.5K -816 -0.3%
AG
7
Artal Group
Luxembourg
$7.98M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$7.3M +$58.8K +1,811 +0.7%
EC
9
EcoR1 Capital
California
$5.77M – – –
Goldman Sachs
10
Goldman Sachs
New York
$3.6M +$107K +3,293 +3%
BBA
11
Baker Bros. Advisors
New York
$3.4M +$2.72M +83,574 +225%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$3.2M +$212K +6,522 +6%
State Street
13
State Street
Massachusetts
$2.77M +$51.7K +1,591 +2%
Morgan Stanley
14
Morgan Stanley
New York
$2.64M -$17.5K -538 -0.6%
UBS Group
15
UBS Group
Switzerland
$2.36M -$98.3K -3,025 -3%
PHS
16
PFM Health Sciences
California
$2.22M -$2.71M -83,458 -51%
Renaissance Technologies
17
Renaissance Technologies
New York
$1.79M -$91.3K -2,810 -4%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$1.68M +$373K +11,473 +24%
Deutsche Bank
19
Deutsche Bank
Germany
$1.57M -$2.25M -69,357 -55%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$1.37M +$142K +4,383 +10%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.37M -$61.3K -1,885 -4%
Charles Schwab
22
Charles Schwab
California
$1.17M +$82.4K +2,535 +7%
Northern Trust
23
Northern Trust
Illinois
$1.03M -$56.5K -1,738 -5%
Los Angeles Capital Management
24
Los Angeles Capital Management
California
$964K -$129K -3,980 -10%
TD Asset Management
25
TD Asset Management
Ontario, Canada
$961K – – –